DIabetic Retinopathy Candesartan Trials.

Clinical trial NCT00252720 · COMPLETED

Trial details

NCT number: NCT00252720
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes

Start date: 2001-08-01
Primary completion: 2008-02-01
Enrollment: 1850

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.